Palonosetron plus dexamethasone effectively prevents acute and delayed chemotherapy-induced nausea and vomiting following highly or moderately emetogenic chemotherapy in pre-treated patients who have failed to respond to a previous antiemetic treatment: Comparison between elderly and non-elderly patient response
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference22 articles.
1. A phase II trial of olanzapine, dexamethasone, and palonosetron for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier oncology group study;Navari;Support Care Cancer,2007
2. Incidence of chemotherapy-induced nausea and emesis after modern antiemetics;Grunberg;Cancer,2004
3. Delayed nausea and vomiting continue to reduce patients’ quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment;Bloechl-Daum;J Clin Oncol,2006
4. Comparative review of 5-HT3 receptor antagonists in the treatment of acute chemotherapy-induced nausea and vomiting;Hesketh;Cancer Invest,2000
5. Clinical practice guidelines in oncology: antiemesis;Ettinger;J Natl Compr Canc Netw,2004
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Using Serious Games to Increase Prevention and Self-Management of Chemotherapy-Induced Nausea and Vomiting in Older Adults With Cancer;Oncology Nursing Forum;2020-09-01
2. Prophylactic aprepitant is better than salvage for carboplatin-based chemotherapy: a propensity score-matched analysis;Medical Oncology;2018-09-05
3. Using a community advisory board to develop a serious game for older adults undergoing treatment for cancer;Applied Nursing Research;2018-02
4. Palonosetron is nonsuperior to ondansetron in acute phase but provides superior antiemetic control in delayed phase for pediatric patients administered highly emetogenic chemotherapy;Pediatric Blood & Cancer;2017-09-22
5. Sequential addition of aprepitant in patients receiving carboplatin-based chemotherapy;Medical Oncology;2016-05-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3